# Treatment of Dural Arteriovenous Fistulas With SQUID™ Liquid Embolic Agent

> **NCT03524976** · — · COMPLETED · sponsor: **Dr. Markus Alfred Möhlenbruch** · enrollment: 50 (actual)

## Conditions studied

- Dural Arteriovenous Fistula

## Interventions

- **DEVICE:** Squid

## Key facts

- **NCT ID:** NCT03524976
- **Lead sponsor:** Dr. Markus Alfred Möhlenbruch
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2020-07-30
- **Final completion:** 2020-08-29
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03524976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03524976, "Treatment of Dural Arteriovenous Fistulas With SQUID™ Liquid Embolic Agent". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03524976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*